Related Experiment Videos
Detection of (1-3)-beta-D-glucan in a rat model of aspergillosis
K Mitsutake1, S Kohno, T Miyazaki
1Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Abstract:
The G test containing factor G, fractioned from the Limulus lysate, was used to detect (1-3)-beta-D-glucan in a rat model of aspergillosis. Aspergillus fumigatus strain MF-13, 1 x 10(4) conidia, were inoculated transtracheally into rats treated with cortisone acetate (100 mg/kg) and fed a low-protein (8%) diet. Increased serum (1-3)-beta-D-glucan was found on the sixth day after inoculation in concentrations of 370 +/- 178 pg/ml (mean +/- SD) in untreated controls, and 154 +/- 43 pg/ml in rats treated with 0.5 mg/kg of amphotericin B. On day 11 (1-3)-beta-D-glucan concentrations were 2,590 +/- 2,940 pg/ml and 448 +/- 442 pg/ml, respectively. The elevation in levels of (1-3)-beta-D-glucan increased in correlation with the elevation of galactomannan antigen titers; (1-3)-beta-D-glucan is thus measurable during experimental aspergillosis in rats.
Insights
The G test can detect (1-3)-beta-D-glucan, a biomarker for fungal infections, in a rat model of aspergillosis. This test shows elevated levels correlating with disease progression, aiding in diagnosis.
Area of Science:
- Medical Mycology
- Biomarker Detection
- Infectious Disease Research
Background:
- Aspergillosis is a serious fungal infection, particularly in immunocompromised individuals.
- Accurate and early diagnosis of invasive fungal infections is critical for effective treatment.
- Current diagnostic methods for aspergillosis have limitations in sensitivity and specificity.
Purpose of the Study:
- To evaluate the utility of the G test for detecting (1-3)-beta-D-glucan in a rat model of experimental aspergillosis.
- To assess the correlation between (1-3)-beta-D-glucan levels and disease progression in this model.
- To investigate the potential of (1-3)-beta-D-glucan as a diagnostic biomarker for aspergillosis.
Main Methods:
- Induction of aspergillosis in rats by transtracheal inoculation of Aspergillus fumigatus conidia.
- Administration of cortisone acetate and a low-protein diet to establish an immunocompromised model.
- Quantification of serum (1-3)-beta-D-glucan levels using the G test at different time points post-inoculation.
- Measurement of galactomannan antigen titers for comparative analysis.
Main Results:
- Serum (1-3)-beta-D-glucan levels were significantly elevated in rats with experimental aspergillosis compared to baseline.
- A temporal correlation was observed between rising (1-3)-beta-D-glucan concentrations and disease progression.
- Elevated (1-3)-beta-D-glucan levels correlated with increased galactomannan antigen titers.
- Amphotericin B treatment showed a trend towards lower (1-3)-beta-D-glucan levels compared to untreated controls.
Conclusions:
- The G test is capable of detecting (1-3)-beta-D-glucan in a rat model of experimental aspergillosis.
- (1-3)-beta-D-glucan is a measurable biomarker that correlates with the progression of aspergillosis in this model.
- These findings suggest that (1-3)-beta-D-glucan detection may serve as a valuable tool for diagnosing and monitoring aspergillosis.